Home » Topics » Regulatory » Patents

Patents
RSS

Rhone-Poulenc Rorer discloses new AMPA/NMDA receptor antagonists

Sep. 30, 1997

Zeneca presents new antibacterials active against resistant pathogens

Sep. 30, 1997

Inhibitors of sCD23 production developed at SmithKline Beecham

Sep. 30, 1997

Symphony discloses AMPA antagonists

Sep. 30, 1997

Endothelin agonists/antagonists from Texas Biotechnology

Sep. 29, 1997

Rhone-Poulenc Rorer discloses excitatory amino acid antagonists

Sep. 29, 1997

Tachykinin antagonists prepared at Pfizer

Sep. 29, 1997

SKB reports new antiplatelet agents

Sep. 29, 1997

New morphinoid delta-opioid ligands from SmithKline Beecham

Sep. 29, 1997

Glaxo Wellcome describes new agents for CMV

Sep. 29, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 27, 2026.
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...